Although the levels of these studied chemokines seem to be associated with inflammation and disease severity (e.g., DMD vs. BMD), there was no significant correlation with timed function tests in DMD nor patient-reported outcomes (NeuroQOL scores) in BMD for CXCL10 and CCL18. The gene discussed is CXCL10; the disease is Duchenne muscular dystrophy.